These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 23460744)

  • 1. Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow.
    Ramachandran IR; Martner A; Pisklakova A; Condamine T; Chase T; Vogl T; Roth J; Gabrilovich D; Nefedova Y
    J Immunol; 2013 Apr; 190(7):3815-23. PubMed ID: 23460744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites.
    Xu X; Zhang C; Trotter TN; Gowda PS; Lu Y; Ponnazhagan S; Javed A; Li J; Yang Y
    Cancer Res; 2020 Mar; 80(5):1036-1048. PubMed ID: 31911552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
    Wang J; De Veirman K; De Beule N; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E
    Oncotarget; 2015 Dec; 6(41):43992-4004. PubMed ID: 26556857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-derived suppressor cells in the development of lung cancer.
    Ortiz ML; Lu L; Ramachandran I; Gabrilovich DI
    Cancer Immunol Res; 2014 Jan; 2(1):50-8. PubMed ID: 24778162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.
    Sinha P; Okoro C; Foell D; Freeze HH; Ostrand-Rosenberg S; Srikrishna G
    J Immunol; 2008 Oct; 181(7):4666-75. PubMed ID: 18802069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells.
    De Veirman K; Van Ginderachter JA; Lub S; De Beule N; Thielemans K; Bautmans I; Oyajobi BO; De Bruyne E; Menu E; Lemaire M; Van Riet I; Vanderkerken K; Van Valckenborgh E
    Oncotarget; 2015 Apr; 6(12):10532-47. PubMed ID: 25871384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.
    Hegde VL; Singh UP; Nagarkatti PS; Nagarkatti M
    J Immunol; 2015 Jun; 194(11):5211-22. PubMed ID: 25917103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma.
    Favaloro J; Liyadipitiya T; Brown R; Yang S; Suen H; Woodland N; Nassif N; Hart D; Fromm P; Weatherburn C; Gibson J; Ho PJ; Joshua D
    Leuk Lymphoma; 2014 Dec; 55(12):2893-900. PubMed ID: 24625328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow.
    Poh TW; Bradley JM; Mukherjee P; Gendler SJ
    Cancer Res; 2009 Apr; 69(8):3554-62. PubMed ID: 19351842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the therapeutic potential of bone marrow-derived myeloid suppressor cell (MDSC) adoptive transfer in mouse models of autoimmunity and allograft rejection.
    Drujont L; Carretero-Iglesia L; Bouchet-Delbos L; Beriou G; Merieau E; Hill M; Delneste Y; Cuturi MC; Louvet C
    PLoS One; 2014; 9(6):e100013. PubMed ID: 24927018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immature myeloid Gr-1+ CD11b+ cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function.
    Landoni VI; Martire-Greco D; Rodriguez-Rodrigues N; Chiarella P; Schierloh P; Isturiz MA; Fernández GC
    Clin Sci (Lond); 2016 Feb; 130(4):259-71. PubMed ID: 26582821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.
    Porembka MR; Mitchem JB; Belt BA; Hsieh CS; Lee HM; Herndon J; Gillanders WE; Linehan DC; Goedegebuure P
    Cancer Immunol Immunother; 2012 Sep; 61(9):1373-85. PubMed ID: 22215137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
    Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
    J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
    Jayaraman P; Parikh F; Lopez-Rivera E; Hailemichael Y; Clark A; Ma G; Cannan D; Ramacher M; Kato M; Overwijk WW; Chen SH; Umansky VY; Sikora AG
    J Immunol; 2012 Jun; 188(11):5365-76. PubMed ID: 22529296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17A deficiency ameliorates streptozotocin-induced diabetes.
    Tong Z; Liu W; Yan H; Dong C
    Immunology; 2015 Oct; 146(2):339-46. PubMed ID: 26211676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of myelodysplasia by myeloid-derived suppressor cells.
    Chen X; Eksioglu EA; Zhou J; Zhang L; Djeu J; Fortenbery N; Epling-Burnette P; Van Bijnen S; Dolstra H; Cannon J; Youn JI; Donatelli SS; Qin D; De Witte T; Tao J; Wang H; Cheng P; Gabrilovich DI; List A; Wei S
    J Clin Invest; 2013 Nov; 123(11):4595-611. PubMed ID: 24216507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
    Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL
    J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage.
    Eggert T; Medina-Echeverz J; Kapanadze T; Kruhlak MJ; Korangy F; Greten TF
    PLoS One; 2014; 9(11):e112717. PubMed ID: 25401795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer.
    Forghani P; Waller EK
    Breast Cancer Res Treat; 2015 Aug; 153(1):21-30. PubMed ID: 26208484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.